Cardiac induced pluripotent stem cells and methods of use in repair and regeneration of myocardium
AssigneeUniversity of Central Florida Research Foundation, Inc.
InventorDinender Singla
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Central Florida Research Foundation, Inc.
InventorDinender Singla
Estimating the term…
Cardiac myocyte differentiation reported thus far is from iPS cells generated from mice and human fibroblasts. iPS cells from cardiac or ventricular specific cell types are generated herein having the potential to repair and regenerate infarcted myocardium. The cells were transduced with four sternness factors and reprogrammed them into iPS cells. These cardiac iPS cells were able to differentiate into beating cardiac myocytes, formed cardiac-specific structures, and positively stained for cardiac specific proteins. Transplanted cells also significantly inhibited apoptosis and fibrosis and improved cardiac function.
A method of repairing or regenerating damaged cardiac tissue due to cardiac dysfunction in a subject in need thereof comprising administering to the subject cardiac induced pluripotent stem cells, derived from a cardiac or ventricular cell type, that stably express one or more inserted stem-cell like factors, wherein the stem-cell like factors comprise Oct3/4, KIf4, Sox2 and c-Myc or any combination thereof;
Cardiac induced pluripotent stem cells, comprising a cardiac or ventricular cell type having a stable vector that expresses at least one stem-cell like factor, wherein the vector comprises the sequence of at least one of Oct3/4, KIf4, Sox2 or c-Myc.
Dependencies are inferred from the claim text.